Status:
COMPLETED
The Effect of Perthes' Disease on Hip Cartilage
Lead Sponsor:
University of British Columbia
Conditions:
Perthes' Disease
Eligibility:
All Genders
17-18 years
Brief Summary
The purpose of this study is to determine whether Perthes' disease has caused detectable hip cartilage damage in young people who have reached the healed stage of the disease.
Detailed Description
We will recruit 20 subjects from our healed Perthes' population. We will use dGEMRIC imaging to identify regions of cartilage degeneration in the femur and acetabulum. Both hips will be imaged so that...
Eligibility Criteria
Inclusion
- Subjects must have reached the healed stage of unilateral Perthes' disease. -Subjects will be between 7 and 18 years of age.
- Subjects must understand English.
Exclusion
- Subjects will be excluded if they have bilateral Perthes' disease or if they have not yet reached the healing stage of the disease.
- Subjects will also be excluded if they do not meet the criteria to have an MRI (e.g., the subject has metal implants, is claustrophobic, has a metallic object in eye or a pacemaker).
- A subject will be excluded if they have any of the precautions for the MR contrast agent, Magnevist, such as pregnancy, breast-feeding, respiratory allergies, asthma, thrombotic syndromes, history of grand mal seizures, impaired renal or hepatic function.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00958464
Start Date
January 1 2008
End Date
June 1 2017
Last Update
October 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Children's Hospital, Department of Orthopaedics
Vancouver, British Columbia, Canada